Bianca Costa Maia do Amaral is a pharmacist and PhD student in Pharmaceutical Sciences at the Federal University of Santa Maria (UFSM), Brazil, supported by a CNPq doctoral fellowship. Her research concentrates on developing pH-responsive and targeted nanocarrier systems that incorporate novel bioactive molecules, especially organoselenium compounds, for anticancer applications. Possess expertise in formulating, characterizing, and evaluating polymeric and lipid-based nanoparticles through in vitro biological tests, including cytotoxicity, safety assessment, cellular uptake, and mechanism-of-action studies using both 2D and 3D cancer cell models. Additional skills encompass chromatographic method development and validation, as well as in silico ADMET predictions. Her contributions to the scientific community include peer-reviewed journal articles, book chapters, and conference presentations in nanomedicine and anticancer drug delivery.